Page 323 - ATP-P 11th Ed

Other notes:
• Do not mix ketamine hydrochloride and diazepam in syringe or infusion bottle.
• Ketamine should not be injected intravenously without proper dilution. It is recom-
mended the drug be diluted with an equal volume of either sterile water for injection,
USP, normal saline, or 5% dextrose in water.
• Protect from light.
• Effects of ketamine are increased when combined with other analgesics or muscle relaxants.
• Vials that develop particulate matter or are discolored should not be used.
TMEP use:
• Procedural Analgesia Protocol
• K9 Trauma Management Protocol
®
Ketorolac (Toradol )
Description: Analgesic, nonsteroidal anti-inflammatory drug (NSAIDs). Inhibits platelet
function.
Indications:
• For the temporary relief of: SECTION 3
° Mild to moderate pain
° Fever (if ASA or Acetaminophen is not available)
Adult dose: 30mg IV/IM. May be repeated q6hr. Do not use more than 5 consecutive days.
Pediatric dose: Adolescents 13–16 years and children 2–12 years: 1mg/kg IM to a maxi-
mum of 30mg or 0.5mg/kg IV to a maximum of 15mg
Contraindications:
• Hypersensitivity to nonsteroidal anti-inflammatory agents (NSAIDs)
• History of gastrointestinal bleeding
• Patients with bleeding disorders (e.g., hemophilia)
• Suspected or confirmed:
° Cerebrovascular bleeding
° Hemorrhagic diathesis
° Incomplete hemostasis
° High risk of bleeding
• Prior to major surgery
• Exercise extreme caution in patients with a history of:
° Hypertension or hypertension and congestive heart failure
° Cardiovascular disease
° Peripheral vascular disease
° Cerebrovascular disease (e.g., stroke, transient ischemic attack)
• Advanced renal impairment
• Patients at risk for renal failure due to volume depletion
Pregnancy Category B

ATP-P Handbook 11th Edition 313